Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

PHASE3CompletedINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Skin and Subcutaneous Tissue Bacterial Infections
Interventions
DRUG

Delafloxacin

Delafloxacin

DRUG

Vancomycin

Vancomycin

DRUG

Aztreonam

Aztreonam

DRUG

Placebo

Placebo

Trial Locations (50)

10000

Melinta Investigational Site, Zagreb

10001

Melinta Investigational Site, Zagreb

13100

Melinta Investigational Site, Safed

16100

Melinta Investigational Site, Nazareth

18009

Melinta Investigational Site, Cherkasy

18014

Melinta Investigational Site, Granada

29010

Melinta Investigational Site, Málaga

31048

Melinta Investigational Site, Haifa

31096

Melinta Investigational Site, Haifa

33027

Melinta Investigational Site, Miramar

35000

Melinta Investigational Site, Slavonski Brod

36106

Melinta Investigational Site, Montgomery

37167

Melinta Investigational Site, Smyrna

44281

Melinta Investigational Site, Kfar Saba

46010

Melinta Investigational Site, Valencia

49005

Melinta Investigational Site, Dnipropetrovsk

49027

Melinta Investigational Site, Dnipropetrovsk

55422

Melinta Investigational Site, Minneapolis

58002

Melinta Investigational Site, Chemivtsi

59701

Melinta Investigational Site, Butte

61037

Melinta Investigational Site, Ivano-Frankivsk

Melinta Investigational Site, Klarkiv

64239

Melinta Investigational Site, Tel Aviv

65025

Melinta Investigational Site, Odesa

69104

Melinta Investigational Site, Zaporizhzhia

76014

Melinta Investigational Site, Ivano-Frankivsk

77469

Melinta Investigational Site, Richmond

79059

Melinta Investigational Site, Lviv

89109

Melinta Investigational Site, Las Vegas

90015

Melinta Investigational Site, Los Angeles

90813

Melinta Investigational Site, Long Beach

91105

Melinta Investigational Site, Pasadena

91911

Melinta Investigational Site, Chula Vista

91942

Melinta Investigational Site, La Mesa

92056

Melinta Investigational Site, Oceanside

92804

Melinta Investigational Site, Anaheim

95204

Melinta Investigational Site, Stockton

95350

Melinta Investigational Site, Modesto

111539

Melinta Investigational Site, Moscow

188640

Melinta Investigational Site, Vsevolozhsk

194354

Melinta Investigational Site, Saint Petersberg

614107

Melinta Investigational Site, Perm

08244

Melinta Investigational Site, Somers Point

LV-5417

Melinta Investigational Site, Daugavpils

LV-3414

Melinta Investigational Site, Liepāja

LV-1002

Melinta Investigational Site, Riga

LV-1006

Melinta Investigational Site, Riga

LV-4201

Melinta Investigational Site, Valmiera

08003

Melinta Investigational Site, Barcelona

08221

Melinta Investigational Site, Barcelona

Sponsors
All Listed Sponsors
lead

Melinta Therapeutics, Inc.

INDUSTRY

NCT01811732 - Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections | Biotech Hunter | Biotech Hunter